Educational programmes for primary prevention of skin cancer (Protocol)
暂无分享,去创建一个
David Hevey | D. Hevey | R. Chan | D. Langbecker | Abbey Diaz | Louise Marquart | L. Marquart | A. Diaz | Danette H. Langbecker | Raymond Javan Chan | Janelle Hamilton | J. Hamilton
[1] J. Spratt. The primary and secondary prevention of cancer , 1981, Journal of surgical oncology.
[2] Claus Garbe,et al. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. , 2008, Advances in experimental medicine and biology.
[3] A. Marghoob,et al. Clinical and Dermoscopic Changes in Common Melanocytic Nevi in School Children: The Framingham School Nevus Study , 2005, Dermatology.
[4] Claus Garbe,et al. The incidence and mortality of cutaneous melanoma in southern Germany , 2006, Cancer.
[5] Omid Azizi Farzan Modarresi,et al. Published by John Wiley & Sons Ltd , 2015 .
[6] A. Stang,et al. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases , 2006, International journal of cancer.
[7] R. MacKie,et al. Development of melanocytic nevi in the first three years of life. , 2000, Journal of the National Cancer Institute.
[8] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[9] R. Stern,et al. Risk Reduction for Nonmelanoma Skin Cancer With Childhood Sunscreen Use , 1986 .
[10] Allan C. Halpern,et al. Skin Cancer Education for Primary Care Physicians: A Systematic Review of Published Evaluated Interventions , 2011, Journal of General Internal Medicine.
[11] V. Preedy,et al. Randomized Controlled Trial , 2010 .
[13] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[14] H. Gollnick,et al. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. , 2012, Journal of the American Academy of Dermatology.
[15] E. D. Smith,et al. Cost of Nonmelanoma Skin Cancer Treatment in the United States , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[16] C. Harper,et al. Frequency of sunburn in Queensland adults: still a burning issue , 2013, The Medical journal of Australia.
[17] Arun D. Singh,et al. Survival rates with uveal melanoma in the United States: 1973-1997. , 2003, Ophthalmology.
[18] Gail M. Williams,et al. Prolonged Prevention of Squamous Cell Carcinoma of the Skin by Regular Sunscreen Use , 2006, Cancer Epidemiology Biomarkers & Prevention.
[19] David B Buller,et al. Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states. , 2011, Journal of the American Academy of Dermatology.
[20] M. Janda,et al. Factors associated with recall of media reports about vitamin D and sun protection , 2011, Australian and New Zealand journal of public health.
[21] R. Marks,et al. Squamous cell carcinoma , 1996, The Lancet.
[22] D. Burdon-Jones,et al. Quality of life issues in nonmetastatic skin cancer , 2010, The British journal of dermatology.
[23] R. Hiatt,et al. Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review. , 2004, American journal of preventive medicine.
[24] Robin Marks,et al. Non‐melanoma skin cancer , 1996, The Medical journal of Australia.
[25] E. Welsh,et al. Home-based educational interventions for children with asthma. , 2011, The Cochrane database of systematic reviews.
[26] Lawrence E Gibson,et al. Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. , 2012, Mayo Clinic proceedings.
[27] V. White,et al. Australian adolescents' sun protection behavior: who are we kidding? , 2007, Preventive medicine.
[28] M. Wakefield,et al. Population and age‐group trends in weekend sun protection and sunburn over two decades of the SunSmart programme in Melbourne, Australia , 2013, The British journal of dermatology.
[29] R. Millikan,et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas , 2007, Cancer Causes & Control.
[30] Claus Garbe,et al. Melanoma epidemiology and trends. , 2009, Clinics in dermatology.
[31] N. Clark,et al. Educational interventions for asthma in children. , 2002, The Cochrane database of systematic reviews.
[32] R. Stern,et al. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. , 2000, Archives of dermatology.
[33] S. Hiom. Public awareness regarding UV risks and vitamin D--the challenges for UK skin cancer prevention campaigns. , 2006, Progress in biophysics and molecular biology.
[34] M. Tucker,et al. Rising Melanoma Incidence Rates of the Trunk among Younger Women in the United States , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[35] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[36] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[37] M. Holick,et al. Sunscreens suppress cutaneous vitamin D3 synthesis. , 1987, The Journal of clinical endocrinology and metabolism.
[38] A. C. Broders. BASAL-CELL EPITHELIOMA , 1919 .
[39] Myles G Cockburn,et al. Increasing burden of melanoma in the United States. , 2009, The Journal of investigative dermatology.
[40] N. Hayward,et al. The effect of MC1R variants and sunscreen on the response of human melanocytes in vivo to ultraviolet radiation and implications for melanoma , 2013, Pigment cell & melanoma research.
[41] Steven R Feldman,et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. , 2003, Journal of the American Academy of Dermatology.
[42] S. Michie,et al. The behaviour change wheel: A new method for characterising and designing behaviour change interventions , 2011, Implementation science : IS.
[43] Brett M Coldiron,et al. No end in sight: the skin cancer epidemic continues. , 2011, Seminars in cutaneous medicine and surgery.
[44] A. Webster,et al. Interventions for preventing non-melanoma skin cancers in high-risk groups. , 2007, The Cochrane database of systematic reviews.
[45] Gail M Williams,et al. Reduced melanoma after regular sunscreen use: randomized trial follow-up. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] P. Gies,et al. Solar and ultraviolet radiation , 2004 .
[47] J. Leonardi-Bee,et al. A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.
[48] J. Lear,et al. Non-melanoma skin cancer , 2010, The Lancet.
[49] Joel L Cohen. Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer. , 2010, The Journal of clinical and aesthetic dermatology.
[50] U. Ringborg,et al. Trends in mortality from malignant melanoma in Sweden, 1970–1996 , 2000, Cancer.
[51] J. Verne,et al. Preventing skin cancer , 2003, BMJ : British Medical Journal.
[52] R. Stern,et al. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. , 2010, Archives of dermatology.
[53] D. English,et al. Incidence of non‐melanocytic skin cancer in Geraldton, Western Australia , 1997, International journal of cancer.
[54] Graham G Giles,et al. Non‐melanoma skin cancer in Australia: the 2002 national survey and trends since 1985 , 2006, The Medical journal of Australia.
[55] G. Giles,et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 , 1996, BMJ.
[56] Roy Armstrong,et al. UV dose determines key characteristics of nonmelanoma skin cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[57] Gail M. Williams,et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial , 1999, The Lancet.